Use: Labeled indications
- INDICATIONS AND USAGE For eradication of scabies ( Sarcoptes scabiei ) and for symptomatic treatment of pruritic skin.
Full indications and usage US FDA label
INDICATIONS AND USAGE For eradication of scabies (Sarcoptes scabiei) and for symptomatic treatment of pruritic skin.
Contraindications
CONTRAINDICATIONS Do not apply Eurax topically to patients who develop a sensitivity or are allergic to it or who manifest a primary irritation response to topical medications.
US FDA labelDosing: Adult
Dosage and administration (US label) US FDA label
DOSAGE AND ADMINISTRATION In Scabies: Thoroughly massage into the skin of the whole body from the chin down, paying particular attention to all folds and creases. A second application is advisable 24 hours later. Change clothing and bed linen the next morning. Take a cleansing bath 48 hours after the last application. In Pruritus: Massage gently into affected areas until medication is completely absorbed.
Repeat as needed. DIRECTIONS FOR PATIENTS WITH SCABIES: Take a routine bath or shower. Thoroughly massage Eurax cream into the skin from the chin to the toes including folds and creases. Put Eurax cream under fingernails after trimming the fingernails short, because scabies are very likely to remain there. A toothbrush can be used to apply the Eurax cream under the fingernails.
Immediately after use, wrap the toothbrush in paper and throw it away. Use of the same brush in the mouth could lead to poisoning. A second application is advisable 24 hours later. A 60 gram tube is sufficient for two applications. Change clothing and bed linen the next day. Dry clean contaminated clothing and bed linen, or wash in the hot cycle of the washing machine.
Take a cleansing bath 48 hours after the last application.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosing: Pediatric
Pediatric use (US label) US FDA label
Pediatric Use Safety and effectiveness in pediatric patients have not been established.
Dosing: Older adult
Geriatric use (US label) US FDA label
Geriatric Use Clinical studies with Eurax (crotamiton, USP) Cream did not include sufficient numbers of subjects aged 65 years and older to determine whether they respond differently than younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.
Dosage forms
Philippines
- ) lotion: 100 mg/g
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Crotamiton as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
CrotagrilCrotamiton | 10% (100 mg/g) LotionHDPE Plastic Bottle x 60 mL (Box of 1's) | OTC | Lloyd Laboratories, Inc.Philippines | Trader: Transcend Phils., Inc. | DRP-7780 | Feb 23, 2032 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
WARNINGS Discontinue treatment with this product if severe irritation or sensitization develops, and institute appropriate therapy.
Drug interactions
Drug interactions (US label) US FDA label
Drug Interactions None known.
Adverse reactions
Adverse reactions (US label) US FDA label
ADVERSE REACTIONS Primary irritation reactions, such as dermatitis, pruritus, and rash, and allergic sensitivity reactions have been reported in a few patients.
Pregnancy considerations
Pregnancy (US label) US FDA label
Pregnancy Animal reproduction studies have not been conducted with Eurax. It is also not known whether Eurax can cause fetal harm when applied topically to a pregnant woman or can affect reproduction capacity. Eurax should be given to a pregnant woman only if clearly needed.
Pharmacokinetics
Pharmacokinetics (US label) US FDA label
CLINICAL PHARMACOLOGY Eurax has scabicidal and antipruritic actions. The mechanisms of these actions are not known. The pharmacokinetics of crotamiton and its degree of systemic absorption following topical application have not been determined.
Formulary and pricing (Philippines)
Formulary and coverage
| Philippine National Formulary | Listed as Crotamiton |
| PNF listing | Lotion: 10%, 60 mL bottle |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Eurax · Journey Medical Corporation [US FDA-approved label, version 2, December 17, 2025]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=99c826aa-c7dd-4e60-be9c-e9c151033d13
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .